Overview

An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A 3-month open label study to evaluate the safety and efficacy of PRX-08066 in patients with pulmonary hypertension and COPD.
Phase:
Phase 2
Details
Lead Sponsor:
Epix Pharmaceuticals, Inc.